pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 13·1 min read
save

Behind Galapagos’ transformation into Lakefront Biotherapeutics

CHICAGO — From a 22nd-floor office overlooking the Chicago Riverwalk, in the heart of the Midwest hub’s white-collar downtown district, Lakefront Biotherapeutics’ executives hope to stage the company’s turnaround. It’s here where the work-in-progress rebranding — and ...

May 13, 2026·read at Endpoints ↗

Henry Gosebruch, Lakefront Biotherapeutics CEO May 13, 2026 09:30 AM EDT PeopleR&DPharma Be­hind Gala­pa­gos’ trans­for­ma­tion in­to Lake­front Bio­ther­a­peu­tics Kyle LaHucik Biotech Correspondent CHICA­GO — From a 22nd-floor of­fice over­look­ing the Chica­go River­walk, in the heart of the Mid­west hub’s white-col­lar down­town dis­trict, Lake­front Bio­ther­a­peu­tics’ ex­ec­u­tives hope to stage … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
83 words · retrieved May 13
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Vyome Holdings, Inc
topics
Cardiology2

related stories

  • May 2Opinion: STAT readers on MAHA activists, perimenopause, and diversity in medical schoolSTAT
  • Apr 30Remembering J. Craig Venter: a relentless scientist who changed biotech — and was all too easily misunderstoodSTAT
  • Apr 30STAT+: In her own words: Surgeon general nominee Nicole Saphier expresses enthusiasm and caution for MAHASTAT
  • Apr 30Trump drops Casey Means as surgeon general nominee, opts for radiologist Nicole SaphierSTAT
  • Apr 30STAT+: Pharmalittle: We’re reading about a Supreme Court hearing on ‘skinny labels,’ AstraZeneca U.K. expansion, and moreSTAT